{"entity":{"type":"insider","cik":"0001579649","url":"/insider/0001579649","json_url":"/insider/0001579649.json","name":"Rosenberg Noah L.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":14,"first":"2019-07-31","last":"2026-08-18","span_basis":"filed_date"},"name_variants":[{"name":"Rosenberg Noah L.","source":"filing","n_filings":14,"first_seen":"2019-07-31","last_seen":"2026-08-18"}],"transactions":[{"id":9292565,"accession":"0001579649-26-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001579649-26-000005","line_url":"/filing/0001579649-26-000005#line-2","is_derivative":false,"issuer_cik":"0001579649","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001579649","owner_cik":"0001579649","owner_name":"Rosenberg Noah L.","owner_display_name":"Rosenberg Noah L.","owner_url":"/insider/0001579649","role":"Officer (CMO)","role_mark":"O","role_mark_label":"Officer (CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CMO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2030.0,"shares_display":"2,030","price_per_share":4.92,"price_display":"4.92","price_state":"stated","total_value":9987.6,"total_display":"9,987.60","total_whole":"9,988","shares_owned_after":8587.0,"shares_owned_after_display":"8,587","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-18","filed_date":"2026-08-18","scope":"insider"},{"id":9292564,"accession":"0001579649-26-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001579649-26-000005","line_url":"/filing/0001579649-26-000005#line-1","is_derivative":false,"issuer_cik":"0001579649","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001579649","owner_cik":"0001579649","owner_name":"Rosenberg Noah L.","owner_display_name":"Rosenberg Noah L.","owner_url":"/insider/0001579649","role":"Officer (CMO)","role_mark":"O","role_mark_label":"Officer (CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CMO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4200.0,"shares_display":"4,200","price_per_share":4.91,"price_display":"4.91","price_state":"stated","total_value":20622.0,"total_display":"20,622.00","total_whole":"20,622","shares_owned_after":6557.0,"shares_owned_after_display":"6,557","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-17","filed_date":"2026-08-18","scope":"insider"},{"id":5016832,"accession":"0001579649-25-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001579649-25-000004","line_url":"/filing/0001579649-25-000004#line-1","is_derivative":false,"issuer_cik":"0001579649","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001579649","owner_cik":"0001579649","owner_name":"Rosenberg Noah L.","owner_display_name":"Rosenberg Noah L.","owner_url":"/insider/0001579649","role":"Officer (CMO)","role_mark":"O","role_mark_label":"Officer (CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CMO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2357.0,"shares_display":"2,357","price_per_share":4.2425,"price_display":"4.24","price_state":"stated","total_value":9999.5725,"total_display":"9,999.57","total_whole":"10,000","shares_owned_after":2357.0,"shares_owned_after_display":"2,357","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-25","filed_date":"2025-11-25","scope":"insider"},{"id":5429829,"accession":"0001209191-21-052083","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-052083","line_url":"/filing/0001209191-21-052083#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001579649","owner_name":"Rosenberg Noah L.","owner_display_name":"Rosenberg Noah L.","owner_url":"/insider/0001579649","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1407.0,"shares_display":"1,407","price_per_share":17.118,"price_display":"17.12","price_state":"stated","total_value":24085.026,"total_display":"24,085.03","total_whole":"24,085","shares_owned_after":47614.0,"shares_owned_after_display":"47,614","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-17","filed_date":"2021-08-17","scope":"insider"},{"id":4838870,"accession":"0001209191-21-048494","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-048494","line_url":"/filing/0001209191-21-048494#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001579649","owner_name":"Rosenberg Noah L.","owner_display_name":"Rosenberg Noah L.","owner_url":"/insider/0001579649","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":13.81,"price_display":"13.81","price_state":"stated","total_value":17262.5,"total_display":"17,262.50","total_whole":"17,263","shares_owned_after":44521.0,"shares_owned_after_display":"44,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-28","filed_date":"2021-07-29","scope":"insider"},{"id":4376469,"accession":"0001209191-21-032319","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-032319","line_url":"/filing/0001209191-21-032319#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001579649","owner_name":"Rosenberg Noah L.","owner_display_name":"Rosenberg Noah L.","owner_url":"/insider/0001579649","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":375.0,"shares_display":"375","price_per_share":19.46,"price_display":"19.46","price_state":"stated","total_value":7297.5,"total_display":"7,297.50","total_whole":"7,298","shares_owned_after":45594.0,"shares_owned_after_display":"45,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-12","filed_date":"2021-05-13","scope":"insider"},{"id":4376465,"accession":"0001209191-21-032319","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-032319","line_url":"/filing/0001209191-21-032319#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001579649","owner_name":"Rosenberg Noah L.","owner_display_name":"Rosenberg Noah L.","owner_url":"/insider/0001579649","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":375.0,"shares_display":"375","price_per_share":19.14,"price_display":"19.14","price_state":"stated","total_value":7177.5,"total_display":"7,177.50","total_whole":"7,178","shares_owned_after":45969.0,"shares_owned_after_display":"45,969","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-11","filed_date":"2021-05-13","scope":"insider"},{"id":4773225,"accession":"0001209191-21-008819","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-008819","line_url":"/filing/0001209191-21-008819#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001579649","owner_name":"Rosenberg Noah L.","owner_display_name":"Rosenberg Noah L.","owner_url":"/insider/0001579649","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1125.0,"shares_display":"1,125","price_per_share":31.58,"price_display":"31.58","price_state":"stated","total_value":35527.5,"total_display":"35,527.50","total_whole":"35,528","shares_owned_after":46344.0,"shares_owned_after_display":"46,344","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-08","filed_date":"2021-02-09","scope":"insider"},{"id":4773222,"accession":"0001209191-21-008819","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-008819","line_url":"/filing/0001209191-21-008819#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001579649","owner_name":"Rosenberg Noah L.","owner_display_name":"Rosenberg Noah L.","owner_url":"/insider/0001579649","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1125.0,"shares_display":"1,125","price_per_share":31.41,"price_display":"31.41","price_state":"stated","total_value":35336.25,"total_display":"35,336.25","total_whole":"35,336","shares_owned_after":47469.0,"shares_owned_after_display":"47,469","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-05","filed_date":"2021-02-09","scope":"insider"},{"id":5035105,"accession":"0001209191-21-007635","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-007635","line_url":"/filing/0001209191-21-007635","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001579649","owner_name":"Rosenberg Noah L.","owner_display_name":"Rosenberg Noah L.","owner_url":"/insider/0001579649","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1813.0,"shares_display":"1,813","price_per_share":28.91,"price_display":"28.91","price_state":"stated","total_value":52413.83,"total_display":"52,413.83","total_whole":"52,414","shares_owned_after":44657.0,"shares_owned_after_display":"44,657","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-03","filed_date":"2021-02-03","scope":"insider","n_lines":2},{"id":5519359,"accession":"0001209191-21-007031","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-007031","line_url":"/filing/0001209191-21-007031","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Travere Therapeutics, Inc.","issuer_ticker":"TVTX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001579649","owner_name":"Rosenberg Noah L.","owner_display_name":"Rosenberg Noah L.","owner_url":"/insider/0001579649","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1813.0,"shares_display":"1,813","price_per_share":30.75,"price_display":"30.75","price_state":"stated","total_value":55749.75,"total_display":"55,749.75","total_whole":"55,750","shares_owned_after":46470.0,"shares_owned_after_display":"46,470","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-02","filed_date":"2021-02-02","scope":"insider","n_lines":2},{"id":3091372,"accession":"0001209191-20-051734","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-051734","line_url":"/filing/0001209191-20-051734#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001579649","owner_name":"Rosenberg Noah L.","owner_display_name":"Rosenberg Noah L.","owner_url":"/insider/0001579649","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750.0,"shares_display":"750","price_per_share":18.48,"price_display":"18.48","price_state":"stated","total_value":13860.0,"total_display":"13,860.00","total_whole":"13,860","shares_owned_after":27555.0,"shares_owned_after_display":"27,555","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-23","filed_date":"2020-09-23","scope":"insider"},{"id":2882859,"accession":"0001209191-20-051614","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-051614","line_url":"/filing/0001209191-20-051614#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001579649","owner_name":"Rosenberg Noah L.","owner_display_name":"Rosenberg Noah L.","owner_url":"/insider/0001579649","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750.0,"shares_display":"750","price_per_share":18.59,"price_display":"18.59","price_state":"stated","total_value":13942.5,"total_display":"13,942.50","total_whole":"13,943","shares_owned_after":28305.0,"shares_owned_after_display":"28,305","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-22","filed_date":"2020-09-22","scope":"insider"},{"id":3199145,"accession":"0001209191-20-044098","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-044098","line_url":"/filing/0001209191-20-044098#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001579649","owner_name":"Rosenberg Noah L.","owner_display_name":"Rosenberg Noah L.","owner_url":"/insider/0001579649","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":870.0,"shares_display":"870","price_per_share":20.49,"price_display":"20.49","price_state":"stated","total_value":17826.3,"total_display":"17,826.30","total_whole":"17,826","shares_owned_after":26055.0,"shares_owned_after_display":"26,055","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-28","filed_date":"2020-07-30","scope":"insider"},{"id":2246513,"accession":"0001209191-20-029021","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-029021","line_url":"/filing/0001209191-20-029021#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001579649","owner_name":"Rosenberg Noah L.","owner_display_name":"Rosenberg Noah L.","owner_url":"/insider/0001579649","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":527.0,"shares_display":"527","price_per_share":16.9843,"price_display":"16.98","price_state":"stated","total_value":8950.7261,"total_display":"8,950.73","total_whole":"8,951","shares_owned_after":26728.0,"shares_owned_after_display":"26,728","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-12","filed_date":"2020-05-13","scope":"insider"},{"id":2040391,"accession":"0001209191-20-017538","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-017538","line_url":"/filing/0001209191-20-017538#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001579649","owner_name":"Rosenberg Noah L.","owner_display_name":"Rosenberg Noah L.","owner_url":"/insider/0001579649","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1790.0,"shares_display":"1,790","price_per_share":15.356,"price_display":"15.36","price_state":"stated","total_value":27487.24,"total_display":"27,487.24","total_whole":"27,487","shares_owned_after":27255.0,"shares_owned_after_display":"27,255","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-05","filed_date":"2020-03-09","scope":"insider"},{"id":7841410,"accession":"0001209191-19-043930","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-043930","line_url":"/filing/0001209191-19-043930#line-2","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001579649","owner_name":"Rosenberg Noah L.","owner_display_name":"Rosenberg Noah L.","owner_url":"/insider/0001579649","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":20.07,"price_display":"20.07","price_state":"stated","total_value":25087.5,"total_display":"25,087.50","total_whole":"25,088","shares_owned_after":13500.0,"shares_owned_after_display":"13,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-31","filed_date":"2019-07-31","scope":"insider"},{"id":7841407,"accession":"0001209191-19-043930","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-043930","line_url":"/filing/0001209191-19-043930#line-1","is_derivative":false,"issuer_cik":"0001438533","issuer_name":"Retrophin, Inc.","issuer_ticker":"RTRX","issuer_name_source":null,"issuer_url":"/issuer/0001438533","owner_cik":"0001579649","owner_name":"Rosenberg Noah L.","owner_display_name":"Rosenberg Noah L.","owner_url":"/insider/0001579649","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":19.82,"price_display":"19.82","price_state":"stated","total_value":24775.0,"total_display":"24,775.00","total_whole":"24,775","shares_owned_after":14750.0,"shares_owned_after_display":"14,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-30","filed_date":"2019-07-31","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":20,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":17,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":20},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001660334","name":"Verrica Pharmaceuticals Inc.","url":"/issuer/0001660334","role":"Officer (CMO)","n_filings":2,"first_seen":"2025-11-25","last_seen":"2026-08-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001438533","name":"Travere Therapeutics, Inc.","url":"/issuer/0001438533","role":"Officer (Chief Medical Officer)","n_filings":12,"first_seen":"2019-07-31","last_seen":"2021-08-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001579649","retrieved_at":"2026-08-22T17:16:38+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}